Cell Therapy

Asia Leaders

Shimon Sakaguchi’s Nobel Prize Has Become a Clinical Manufacturing Test

Shimon Sakaguchi’s discoveries gave immunology a new control system. RegCell’s planned US and Japanese trials will test whether that science can become a scalable autoimmune therapy rather than another elegant but expensive cell-therapy proposition.

Asia Leaders

Shinya Yamanaka Built Japan’s iPS Infrastructure. Personalised Cell Therapy Must Now Clear the Cost Barrier

Shinya Yamanaka has spent two decades turning cellular reprogramming into shared infrastructure. His next test is whether patient-specific iPS cells can be made reliably and cheaply enough for Asian health systems.